Neonatal randomised point-of-care trials are feasible and acceptable in the UK: results from two national surveys by Gale, C & Modi, N
LETTER
Neonatal randomised point-
of-care trials are feasible and
acceptable in the UK: results
from two national surveys
Randomised point-of-care trials (POCT)1
or registry trials2 offer a potentially
efﬁcient, convenient and cost-effective
alternative to conventional randomised
controlled trials. By using information
present in an existing database, registry or
electronic patient record (EPR), POCT
eliminate the need for duplicative data col-
lection.1 Neonatal medicine is well placed
to use this methodology; an existing
national resource, the National Neonatal
Research Database (NNRD), holds
detailed data extracted from the neonatal
EPR of all National Health Service
neonatal units in England, Wales and
Scotland; contributing units are known as
the UK Neonatal Collaborative (UKNC).
We assessed the acceptability of neonatal
POCT using the NNRD in two surveys. In
the ﬁrst (March–June 2014), we emailed all
English UKNC leads, proposed a neonatal
POCT and asked whether their unit would
be willing to participate. In the second, we
examined attitudes towards the neonatal
EPR. We emailed neonatal trainees
(n=108) and lead nurses, and asked them
to cascade the survey on their unit. Using
validated3 questions, we asked respondents
about their current satisfaction with the
EPR; POCT methodology was then
described, and respondents rated their pre-
dicted satisfaction with using EPR data in
this way using a Likert scale.
A total of 111/163 (68%) UKNC
neonatal unit contacts responded to the
ﬁrst survey; 97/111 (87%) respondents
expressed willingness for their neonatal
unit to take part in the proposed POCT.
A total of 162 neonatal health professionals
responded to the second survey.
Respondents were generally satisﬁed with
the neonatal EPR (table 1). Approximately
one in three indicated that using EPR data
for POCT would lead them to view it as
more worthwhile (table 2). A total of 139/
157 (88%) respondents agreed with the
statement, ‘if parents’ consent, I support
using the EPR system to gather data for ran-
domised trials’. The theme that emerged
from narrative responses concerned EPR
data quality.
We show that neonatal practitioners in
England are willing to participate in
POCT using EPR. Using neonatal data in
this way is acceptable, and associated
with greater satisfaction with the EPR in
approximately one-third of the respon-
dents. There is currently a high level of
satisfaction with the UK neonatal EPR.
Those surveyed have identiﬁed the need
to improve EPR data quality; the neo-
natal EPR is used clinically and to gener-
ate discharge summaries, so enhancing
data quality could also beneﬁt patient
care. Strengths include the national distri-
bution and high response rates, although
the voluntary nature may mean indivi-
duals with enthusiasm for the EPR are
over-represented.
Neonatal practice is insufﬁciently evi-
dence-based; 58% of neonatal Cochrane
reviews published between 2006 and 2010
were inconclusive.4 Using existing EPR for
randomised POCT would represent an
important innovation, potentially improv-
ing neonatal care rapidly, and at lower cost
than is presently the case. The results of our
study are encouraging, and suggest that this
approach would be well received, and
increase the perceived utility of the EPR.
We are currently undertaking work to
understand parent views and determine
research types suitable for this method-
ology. In conclusion, POCTusing EPR and
the NNRD are feasible and acceptable to
health professionals.
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Table 1 Current satisfaction with the neonatal electronic patient record (EPR)
Agreement, all
Agreement,
doctors
Agreement,
nurses
I feel that the EPR is useful 148/162 (91%) 38/40 (95%) 95/106 (90%)
The EPR is worth the time and effort required to use it 134/162 (83%) 30/40 (75%) 91/106 (86%)
Overall, I am satisfied with the electronic patient record 126/162 (79%) 28/40 (70%) 86/106 (82%)
Data are presented as n/N (%)
Table 2 How respondent’s perceptions would change if electronic patient record (EPR) data were used for point-of-care trials
Stronger
agreement, all
Less
agreement, all
Stronger
agreement,
doctors
Less
agreement,
doctors
Stronger
agreement,
nurses
Less
agreement,
nurses
The EPR is useful 50/162 (32%) 4/162 (3%) 18/40 (46%) 4/40 (10%) 27/106 (26%) 0/106 (0%)
The EPR is worth the time and effort required to use it 55/162 (35%) 3/162 (2%) 19/40 (50%) 3/40 (7%) 33/106 (32%) 0/106 (0%)
Overall, I am satisfied with the electronic patient record 42/162 (27%) 5/162 (3%) 16/40 (43%) 5/40 (13%) 22/106 (21%) 0/106 (0%)
Data are presented as n/N (%)
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